Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ALBIREO PHARMA, INC. | y88343e10vk.htm |
| EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | y88343exv23w1.htm |
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | y88343exv21w1.htm |
| EX-31.02 - EX-31.02 - ALBIREO PHARMA, INC. | y88343exv31w02.htm |
| EX-31.01 - EX-31.01 - ALBIREO PHARMA, INC. | y88343exv31w01.htm |
| EX-32.01 - EX-32.01 - ALBIREO PHARMA, INC. | y88343exv32w01.htm |
| EX-10.24 - EX-10.24 - ALBIREO PHARMA, INC. | y88343exv10w24.htm |
Exhibit 10.23
BASE
SALARIES OF NAMED EXECUTIVE OFFICERS OF THE REGISTRANT
The
following are the base salaries (on an annual basis) of the named executive officers
of the Company:
| Name and Title | Base Salary(1) | |||
Errol De Souza President and Chief Executive Officer |
$ | 450,000 | ||
Solomon S. Steiner Chief Scientific Officer |
$ | 400,000 | ||
Gerard J. Michel Chief Financial Officer, Vice President Corporate Development and Treasurer |
$ | 317,000 | ||
Alan Krasnser Chief Medical Officer |
$ | 312,000 | ||
Paul Bavier General Counsel and Secretary |
$ | 210,000 | ||
| (1) | Base salaries effective March 31, 2010 for CEO and CSO, and December 1, 2009 for other named executive officers. |